Cutis-Biotech, a pharmaceutical firm, filed a suit in the civil court claiming it was a prior user of the brandname Covishield, and sought to restrain SII from using the name.
In a tweet, Serum Institute of India CEO Adar Poonawalla said, "Our partnership for a Covid-19 vaccine with Novavax has also published excellent efficacy results.”
Covaxin is contraindicated for people who use blood thinners, while Covishield asks recipients to inform physician. But doctors say there’s no rationale.
SII official says Covishield vaccines are safe and the manufacturing site is also unaffected after fire breaks out at the Serum Institute's Manjari facility, which is under construction.
Dhaka’s announcement comes a day after a meeting between the Modi govt and vaccine makers Bharat Biotech and SII to discuss India’s export plan for Covid vaccines.
Analysts say supply to government amid low distribution, marketing and R&D costs could aid profits. Bharat Biotech vaccine is priced at Rs 206 per dose while SII’s is at Rs 200.
Covishield will reach Brazil next week. Modi govt had earlier this month authorised a deal between Brazilian govt & Serum Institute to supply the vaccine at a ‘special rate’.
Govt firm will buy vaccines from Serum Institute of India & Bharat Biotech and supply them to Nepal, Bangladesh, Sri Lanka, Afghanistan, Seychelles and Mauritius.
Once seen as a fading presence on India’s investment & startup picture, the state is slowly moving up the ladder, with policy reforms & infrastructure building.
Agreement signed during 17th Joint Working Group (JWG) on defence cooperation. Defence Secretary Rajesh Kumar Singh met Director General in Israeli Ministry of Defence Amir Baram Tuesday.
This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.
Playing GOD will cost lives.